James C Pierce

Title: Innovations of James C. Pierce

Introduction

James C. Pierce is an accomplished inventor based in Wilmington, DE (US). He holds 2 patents that contribute significantly to the fields of biotechnology and molecular biology. His work focuses on the recombinant production of biologically active peptides and proteins, showcasing his expertise in innovative scientific methods.

Latest Patents

One of his latest patents is titled "Recombinant production of biologically active peptides and proteins." This invention relates to the recombinant production of amphiphilic peptides with biologically and therapeutically significant activities. In one embodiment, the invention involves using a protease-deficient microbial host transformed with an expression vector containing DNA that encodes the amphiphilic peptide. The peptide is expressed in the transformed microbial host, allowing for the production of biologically active amphiphilic peptides that can be further treated to enhance their properties.

Another significant patent is "Positive selection vector for the bacteriophage P1 cloning system." This patent discloses positive selection cassettes that contain a lethal gene, a promoter, a repressor sequence, and a cloning site. Insertion of a foreign nucleic acid sequence into the cloning site prevents the expression of the lethal gene, allowing for the selection of successful clones.

Career Highlights

James C. Pierce has worked with notable companies such as E.I. du Pont de Nemours and Company and Magainin Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to biotechnology.

Collaborations

Throughout his career, James has collaborated with esteemed colleagues, including Nat L. Sternberg and Jon I. Williams. These collaborations have contributed to his success and the advancement of his inventions.

Conclusion

James C. Pierce is a notable inventor whose work in recombinant biotechnology has led to significant advancements in the production of biologically active peptides and proteins. His contributions continue to impact the field positively.